Cytokine_influence_on_killing_of_fresh_chronic_lymphocytic_leukemia_cells_by_human_leukocytes._The_feasibility_of_combining_the_Lym-1_monoclonal_antibody_(MoAb)_with_interferon-gamma_(IFN-gamma)_in_the_treatment_of_chronic_lymphocytic_leukemia_(CLL)_was_evaluated._We_used_an_in_vitro_tumor_lysis_model_that_incorporated_fresh_CLL_cells_from_21_different_patients_as_targets_for_two_distinct_normal_human_leukocyte_effector_subsets,_neutrophils,_and_peripheral_blood_mononuclear_cells_(PBMCs)._Lym-1_antigen_(Lym-1-Ag)_expression_varied_greatly_and_did_not_correlate_with_the_expression_of_other_CLL-associated_antigens_such_as_CD5,_CD19,_or_HLA-DR._CLL_cells_were_not_lysed_by_neutrophils_alone_or_with_IFN-gamma_in_the_absence_of_Lym-1._Neutrophil_Lym-1-dependent_cytotoxicity_(ADCC)_in_the_absence_of_IFN-gamma_was_weak_and_inconsistent._IFN-gamma_exposure_induced_MoAb-dependent_lysis_of_80%_of_21_CLL_targets_and_resulted_in_an_eightfold_augmentation_of_neutrophil_ADCC_against_the_remainder._Cytotoxicity_correlated_directly_and_positively_with_Lym-1-Ag_expression._Confirmation_of_the_need_for_interaction_between_neutrophil_IgG_Fc_receptors_(Fc_gamma_Rs)_and_the_Fc_portion_of_the_Lym-1_MoAb_was_obtained_by_demonstrating_that_purified_Staphylococcus_aureus_Protein_A_(SpA)_inhibited_ADCC._IFN-gamma_exposure_caused_no_consistent_alternations_in_Lym-1-Ag_expression_on_CLL_cells_so_that_target_antigen_upregulation_was_unlikely_to_account_for_augmentation_of_neutrophil_ADCC._PBMCs_alone,_exposed_to_interkeukin-2_(IL-2)_or_IFN-gamma,_or_with_Lym-1_in_the_presence_or_absence_of_IL-2_or_IFN-gamma_were_unable_to_lyse_CLL_targets._PBMCs_were_able_to_kill_Raji_Burkitt_lymphoma_cells_in_conjunction_with_Lym-1,_so_their_ability_to_interact_with_Lym-1-coated_targets_and_their_lytic_functions_appeared_intact._These_results_emphasize_the_importance_of_examining_fresh_tumor_cells_with_different_leukocyte_effector_subsets_before_designing_a_clinical_trial_that_combines_a_therapeutic_MoAb_with_a_cytokine.